A population-based assessment of systemic lupus erythematosus incidence and prevalence - Results and implications of using administrative data for epidemiological studies

Rheumatology

Volumn 46, Issue 12, 2007, Pages 1814-1818

  Bernatsky, S ^a,b   Joseph, L ^a,b   Pineau, C A ^b   Tamblyn, R ^b   Feldman, D E ^c   Clarke, A E ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Epidemiology; Incidence; Prevalence; Systemic lupus erythematosus

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; FEMALE; GOLD STANDARD; HOSPITAL INFORMATION SYSTEM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL FEE; MEDICAL SPECIALIST; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SYSTEMIC LUPUS ERYTHEMATOSUS; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BAYES THEOREM; CONFIDENCE INTERVALS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; QUEBEC; REGISTRIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 36448957611     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem233     Document Type: Article

References (19)

1. Insinge, RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: A populaton-based study. Am J Obstet Gyne 2004;191:105-13.
2. Luthi JC, Flanders WD, Pitts SR, Bumand B, McClellan WM. Outcomes and the quality of care for pabents hospitalized with heart failure. Int J Qual Health Care 2004;16:201-10.
3. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 2004;161:1090-5.
4. Losina E, Barrett J, Baron JA Katz JN. Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003;56:515-9.
5. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004;57:131-41.
6. Statistique Canada. Institut de la statistique du Québec. Population, Québec at Canada. Recensements du Canada at estimations de la population 2004.
7. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims data-bases in pharmacospidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epiderniol 1995;48:999-1009.
8. Ashby D. Bayesian statistics in medicine: A 25 year review. Stat Med 2006;15:3589-631.
9. Ladoucaur M, Rahme E, Pineau C, Joseph L. Robustness of prevalence estimates derived from misclassified data from administrative databases. Biometrics; 2007;63:272-9.
10. Bematsky S, Joseph L, Bélisle P et al. Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat Med 2005;24:2365-79.
11. Joseph L, Gyorkos T, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol 1995;141:263-72.
12. Uramoto K, Michet CJ, Thumboo J, Sunku J, O'Fallon W, Gabriel S. Trends in the incidence and mortality of systemic lupus arythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50.
13. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995;38:1260-70.
14. Hochberg MC, Perlmutter DL, Medsger TA et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995;4:454-6.
15. Naloway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005;14:862-6.
16. Peschken C, Esdaile J. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000;27:1884-91.
17. Lofstrom B, Backlin C, Sundstrom C, Ekbom A, Lundberg I. Lymphoma subtypes and prognosis in patients with systemic lupus erythematosus. Arthritis Rheum 2005;9(Suppl.):S1960.
18. Katz JN, Barrett J, Liang MH et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheurnatologic diagnoses and procedures. Arthritis Rheum. 1997;40:1594-600.
19. Nightingale AL, Farmer RDT, de Vries CS. Systemic lupus erythematosus prevalence in the U.K.: Methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Safety 2007;16:144-51.